|Bid||2.8100 x 1200|
|Ask||3.2400 x 1100|
|Day's Range||2.8100 - 2.9500|
|52 Week Range||2.8100 - 24.4500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Because of the investment, the Houston pharmaceutical company has additional capital to advance its cancer drug through clinical trials.
A look at the shareholders of Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) can tell us which group is most powerful...